PT  - JOURNAL ARTICLE
AU  - Rohrberg, Kristoffer Staahl
AU  - Papai, Zsuzsanna
AU  - Carneiro, Ana
AU  - Lang, Istvan
AU  - Yachnin, Jeffrey
AU  - Lim, Sean
AU  - Ny, Lars
AU  - Lovendahl Eefsen, Rikke H
AU  - Walter, Harriet
AU  - Abel, Edvard
AU  - Cleary, Kirstie
AU  - Oldham, Robert
AU  - Cragg, Mark
AU  - Borggren, Marie
AU  - Gertsson, Susanne
AU  - Holmkvist, Petra
AU  - Karlsson, Ingrid
AU  - Martensson, Linda
AU  - Nilsson, Jan Anders
AU  - Wallin, Johan E
AU  - Chisamore, Michael
AU  - Frendeus, Bjorn
AU  - Teige, Ingrid
AU  - McAllister, Andres
TI  - 757 Phase 1/2a clinical trial of BI-1808, a monoclonal antibody to tumor necrosis factor receptor 2 (TNFR2) as single agent and in combination with pembrolizumab
AID  - 10.1136/jitc-2023-SITC2023.0757
DP  - 2023 Nov 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - A853--A853
VI  - 11
IP  - Suppl 1
4099  - http://jitc.bmj.com/content/11/Suppl_1/A853.short
4100  - http://jitc.bmj.com/content/11/Suppl_1/A853.full
SO  - J Immunother Cancer2023 Nov 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.